Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells
Pengju Wang(Henan Medical University), Lintao Jia(Air Force Medical University)
Cited by 17
Related Papers
Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R
|BMC Cancer|2014|120
Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab
|Signal Transduction and Targeted Therapy|2021|105